Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes (Q38254025)

1 September 2017

1 reference

title

Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes (English)

1 reference

1 September 2017

2

Mihai Gheorghiade

1 reference

1 September 2017

5

Javed Butler

1 reference

1 September 2017

Andrew P Ambrosy

1

1 reference

1 September 2017

Ovidiu Chioncel

series ordinal

3

1 reference

1 September 2017

Robert J Mentz

series ordinal

4

1 reference

1 September 2017

1 December 2014

1 reference

Current heart failure reports

1 September 2017

1 reference

1 September 2017

11

1 reference

1 September 2017

416-427

1 reference

1 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-014-0221-9

1 September 2017

0 references

cites work

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Clinical epidemiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Heart failure in 2010: one step forward, two steps back

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Improving postdischarge outcomes in patients hospitalized for acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

A proposed model for initial assessment and management of acute heart failure syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Heart failure–associated hospitalizations in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Epidemiology of acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Heart failure burden and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Implications of geographical variation on clinical outcomes of cardiovascular trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

The burden of heart failure in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Heart failure in women: a need for prospective data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Characteristics and outcomes in African American patients with decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Sleep-disordered breathing in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Prognostic value of anxiety and depression in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Troponin elevation in heart failure prevalence, mechanisms, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

HFSA 2010 Comprehensive Heart Failure Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

The disconnect between phase II and phase III trials of drugs for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

The potential role of cardiac resynchronization therapy in acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) progr

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Influence of global region on outcomes in heart failure β-blocker trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Spironolactone for heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Geographic variation in heart failure trials: time for scepticism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Executive Summary: Heart Disease and Stroke Statistics—2014 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

The potential application of electrophysiology diagnostics and therapeutics in acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Lessons from the TOPCAT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Strategies and Opportunities for Drug Development in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-014-0221-9

Patterns of intensive care unit admissions in patients hospitalized for heart failure: insights from the RO-AHFS registry

21 January 2018

1 reference

12 December 2020

International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

1 reference

12 December 2020

Heart failure with preserved ejection fraction: treat now by treating comorbidities

1 reference

12 December 2020

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

1 reference

12 December 2020

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association

1 reference

12 December 2020

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry).

1 reference

12 December 2020

The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry

1 reference

12 December 2020

Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

1 reference

12 December 2020

10.1007/S11897-014-0221-9

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1016133026

0 references

Fatcat ID

release_vyceu5o4lzgrlefush7xsho6ba

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vyceu5o4lzgrlefush7xsho6ba

24 November 2022

mapped directly with Wikidata item

1 reference